| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-10 | 2025-03-26 | 2024-04-15 | 2023-04-27 | 2022-05-02 | 2020-12-31 | 2019-12-31 |
| Revenue | 14.48 | 12.87 | 10.07 | 6.01 | 4.25 | 0 | 0 |
| Cost of Revenue | 4.83 | 5.02 | 5.06 | 3.28 | 1.88 | 0 | 0 |
| Gross Profit | 9.65 | 7.85 | 5.02 | 2.73 | 2.37 | 0 | 0 |
| Operating Expenses | 45 | 60.05 | 74.42 | 93.59 | 71.01 | 22.41 | 20.7 |
| Research & Development | 10.06 | 14.4 | 10.66 | 13.05 | 9.64 | 5.92 | 6.37 |
| Selling, General and Administrative | 16.52 | 30.53 | 33.84 | 55.95 | 46.59 | 8.12 | 8.24 |
| Other Operating Expenses | 18.42 | 15.12 | 29.92 | 24.59 | 14.78 | 8.37 | 6.09 |
| Operating Income | -35.35 | -52.21 | -69.4 | -90.87 | -68.64 | -22.41 | -20.7 |
| Net Non-Operating Interest | 0.713 | 0.97 | 1.85 | -0.432 | -8.69 | -7.44 | -4.07 |
| Interest Income | 0.789 | 1.04 | 1.9 | 1.16 | 0.036 | 0.079 | 0.398 |
| Interest Expense | 0.076 | 0.071 | 0.051 | 1.6 | 8.73 | 7.52 | 4.47 |
| Equity & Other Income/(Expense) | -40.8 | -62.18 | 15.62 | 59.23 | -19.21 | 8.47 | 4.08 |
| Income Before Tax | -75.43 | -113.4 | -51.94 | -32.07 | -96.54 | -21.38 | -20.68 |
| Income Tax Expense | 1.33 | 2.86 | 9.08 | 4.57 | -0.232 | 0.148 | 0.083 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -76.76 | -116.3 | -61.02 | -36.64 | -96.31 | -21.53 | -20.77 |
| Depreciation and Amortization | 9.39 | 12.65 | 17.26 | 14.33 | 10.73 | 3.03 | 4.24 |
| EBITDA | -25.96 | -39.55 | -52.15 | -76.54 | -57.91 | -19.38 | -16.46 |
| Earnings Per Share (EPS) | -0.815 | -1.28 | -0.68 | -0.44 | -1.4 | -2.26 | -0.3 |
| Diluted Earnings Per Share | -0.875 | -1.28 | -0.68 | -0.66 | -1.4 | -2.26 | -0.3 |
| Weighted Average Shares Outstanding | 106 | 91.16 | 89.54 | 83.19 | 68.82 | 50.34 | 68.82 |
| Diluted Weighted Average Shares Outstanding | 131 | 91.16 | 89.54 | 83.8 | 68.82 | 50.34 | 68.82 |
